nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—psoriasis—atopic dermatitis	0.567	1	CtDrD
Methotrexate—ALB—Tacrolimus—atopic dermatitis	0.0278	0.126	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—atopic dermatitis	0.0232	0.105	CbGbCtD
Methotrexate—SLCO1A2—Hydrocortisone—atopic dermatitis	0.0219	0.0994	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—atopic dermatitis	0.0219	0.099	CbGbCtD
Methotrexate—ABCG2—Hydrocortisone—atopic dermatitis	0.0164	0.0745	CbGbCtD
Methotrexate—ABCB1—Tacrolimus—atopic dermatitis	0.0146	0.066	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—atopic dermatitis	0.0136	0.0618	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—atopic dermatitis	0.0113	0.0512	CbGbCtD
Methotrexate—ALB—Prednisone—atopic dermatitis	0.0113	0.0511	CbGbCtD
Methotrexate—ABCB1—Loratadine—atopic dermatitis	0.0107	0.0483	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—atopic dermatitis	0.0102	0.0463	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—atopic dermatitis	0.00975	0.0442	CbGbCtD
Methotrexate—ABCB1—Betamethasone—atopic dermatitis	0.00634	0.0287	CbGbCtD
Methotrexate—ABCB1—Prednisolone—atopic dermatitis	0.00626	0.0283	CbGbCtD
Methotrexate—ABCB1—Hydrocortisone—atopic dermatitis	0.00593	0.0269	CbGbCtD
Methotrexate—ABCB1—Prednisone—atopic dermatitis	0.00591	0.0268	CbGbCtD
Methotrexate—ABCB1—Dexamethasone—atopic dermatitis	0.00369	0.0167	CbGbCtD
Methotrexate—ATIC—skin epidermis—atopic dermatitis	0.00261	0.165	CbGeAlD
Methotrexate—GGH—skin of body—atopic dermatitis	0.000952	0.0602	CbGeAlD
Methotrexate—FOLR1—head—atopic dermatitis	0.000935	0.0591	CbGeAlD
Methotrexate—MTHFR—neck—atopic dermatitis	0.00093	0.0588	CbGeAlD
Methotrexate—FPGS—skin of body—atopic dermatitis	0.000837	0.0529	CbGeAlD
Methotrexate—SLC19A1—head—atopic dermatitis	0.00082	0.0519	CbGeAlD
Methotrexate—ATIC—skin of body—atopic dermatitis	0.00081	0.0512	CbGeAlD
Methotrexate—PGD—neck—atopic dermatitis	0.000808	0.0511	CbGeAlD
Methotrexate—SLC46A1—head—atopic dermatitis	0.000632	0.0399	CbGeAlD
Methotrexate—GGH—head—atopic dermatitis	0.000621	0.0393	CbGeAlD
Methotrexate—TYMS—skin of body—atopic dermatitis	0.000549	0.0347	CbGeAlD
Methotrexate—FPGS—head—atopic dermatitis	0.000546	0.0345	CbGeAlD
Methotrexate—ATIC—head—atopic dermatitis	0.000528	0.0334	CbGeAlD
Methotrexate—PGD—skin of body—atopic dermatitis	0.000523	0.0331	CbGeAlD
Methotrexate—ATIC—Everolimus—Tacrolimus—atopic dermatitis	0.000516	0.142	CbGdCrCtD
Methotrexate—ATIC—Everolimus—Pimecrolimus—atopic dermatitis	0.000516	0.142	CbGdCrCtD
Methotrexate—SLCO1C1—head—atopic dermatitis	0.000439	0.0278	CbGeAlD
Methotrexate—FPGS—Everolimus—Pimecrolimus—atopic dermatitis	0.000438	0.12	CbGdCrCtD
Methotrexate—FPGS—Everolimus—Tacrolimus—atopic dermatitis	0.000438	0.12	CbGdCrCtD
Methotrexate—MTHFR—head—atopic dermatitis	0.000393	0.0248	CbGeAlD
Methotrexate—SLCO3A1—head—atopic dermatitis	0.000386	0.0244	CbGeAlD
Methotrexate—TYMS—head—atopic dermatitis	0.000358	0.0227	CbGeAlD
Methotrexate—DHFR—head—atopic dermatitis	0.000355	0.0224	CbGeAlD
Methotrexate—PGD—head—atopic dermatitis	0.000341	0.0216	CbGeAlD
Methotrexate—SLC16A1—head—atopic dermatitis	0.000318	0.0201	CbGeAlD
Methotrexate—ABCC3—head—atopic dermatitis	0.000294	0.0186	CbGeAlD
Methotrexate—SLCO1A2—head—atopic dermatitis	0.000252	0.0159	CbGeAlD
Methotrexate—ABCC4—head—atopic dermatitis	0.000243	0.0153	CbGeAlD
Methotrexate—SLC22A8—head—atopic dermatitis	0.000241	0.0152	CbGeAlD
Methotrexate—MTHFR—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000128	0.00455	CbGpPWpGaD
Methotrexate—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000122	0.00435	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000121	0.0043	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000118	0.00422	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000114	0.00406	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—GLB1—atopic dermatitis	0.000112	0.004	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—TNF—atopic dermatitis	0.000112	0.00397	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00011	0.0039	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000104	0.00371	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IFNG—atopic dermatitis	0.000104	0.00371	CbGpPWpGaD
Methotrexate—TYMS—Sirolimus—Tacrolimus—atopic dermatitis	0.000103	0.0283	CbGdCrCtD
Methotrexate—TYMS—Sirolimus—Pimecrolimus—atopic dermatitis	0.000103	0.0283	CbGdCrCtD
Methotrexate—FPGS—Disease—GLB1—atopic dermatitis	9.53e-05	0.0034	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GLB1—atopic dermatitis	9.39e-05	0.00335	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	9.39e-05	0.00335	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IL1B—atopic dermatitis	9.27e-05	0.00331	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IL2—atopic dermatitis	9.24e-05	0.00329	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IFNG—atopic dermatitis	9.24e-05	0.00329	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	9.21e-05	0.00328	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—ADSL—atopic dermatitis	9e-05	0.00321	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—IL6—atopic dermatitis	9e-05	0.00321	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.9e-05	0.00317	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.9e-05	0.00317	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.83e-05	0.00315	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	8.72e-05	0.00311	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	8.55e-05	0.00305	CbGpPWpGaD
Methotrexate—ABCB1—head—atopic dermatitis	8.44e-05	0.00534	CbGeAlD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.44e-05	0.00301	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—NPS—atopic dermatitis	8.27e-05	0.00295	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—TNF—atopic dermatitis	8.27e-05	0.00295	CbGpPWpGaD
Methotrexate—TYMS—Alverine—Diphenhydramine—atopic dermatitis	8.26e-05	0.0227	CbGdCrCtD
Methotrexate—MTHFR—Selenium Micronutrient Network—IFNG—atopic dermatitis	8.26e-05	0.00294	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IL1B—atopic dermatitis	8.24e-05	0.00294	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IL2—atopic dermatitis	8.21e-05	0.00293	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.17e-05	0.00291	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.05e-05	0.00287	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GLB1—atopic dermatitis	7.99e-05	0.00285	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GLB1—atopic dermatitis	7.99e-05	0.00285	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	7.91e-05	0.00282	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.68e-05	0.00274	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ADSL—atopic dermatitis	7.66e-05	0.00273	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ADSL—atopic dermatitis	7.66e-05	0.00273	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	7.52e-05	0.00268	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—SLC11A1—atopic dermatitis	7.51e-05	0.00268	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.44e-05	0.00265	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—GLB1—atopic dermatitis	7.43e-05	0.00265	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—IL1B—atopic dermatitis	7.37e-05	0.00263	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.36e-05	0.00262	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.99e-05	0.00249	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	6.84e-05	0.00244	CbGpPWpGaD
Methotrexate—PGD—Disease—GLB1—atopic dermatitis	6.79e-05	0.00242	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.74e-05	0.0024	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TNF—atopic dermatitis	6.73e-05	0.0024	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—IL6—atopic dermatitis	6.67e-05	0.00238	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	6.65e-05	0.00237	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.51e-05	0.00232	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.47e-05	0.00231	CbGpPWpGaD
Methotrexate—FPGS—Disease—SLC11A1—atopic dermatitis	6.39e-05	0.00228	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—KIF3A—atopic dermatitis	6.28e-05	0.00224	CbGpPWpGaD
Methotrexate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.23e-05	0.00222	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GLB1—atopic dermatitis	6.22e-05	0.00222	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.14e-05	0.00219	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6e-05	0.00214	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TNF—atopic dermatitis	5.98e-05	0.00213	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ADSL—atopic dermatitis	5.96e-05	0.00213	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	5.96e-05	0.00212	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	5.91e-05	0.0021	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL13—atopic dermatitis	5.86e-05	0.00209	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GLB1—atopic dermatitis	5.69e-05	0.00203	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	5.55e-05	0.00198	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	5.55e-05	0.00198	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ADSL—atopic dermatitis	5.45e-05	0.00194	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IL6—atopic dermatitis	5.43e-05	0.00194	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.41e-05	0.00193	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	5.39e-05	0.00192	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—TNF—atopic dermatitis	5.35e-05	0.00191	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—SELE—atopic dermatitis	5.06e-05	0.0018	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	5.05e-05	0.0018	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL5—atopic dermatitis	5.01e-05	0.00179	CbGpPWpGaD
Methotrexate—ATIC—Levonorgestrel—Hydrocortisone—atopic dermatitis	4.99e-05	0.0137	CbGdCrCtD
Methotrexate—SLC46A1—Disease—SLC11A1—atopic dermatitis	4.98e-05	0.00177	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—PPARA—atopic dermatitis	4.88e-05	0.00174	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IL6—atopic dermatitis	4.82e-05	0.00172	CbGpPWpGaD
Methotrexate—Pruritus—Tacrolimus—atopic dermatitis	4.77e-05	0.000291	CcSEcCtD
Methotrexate—Malaise—Prednisolone—atopic dermatitis	4.76e-05	0.00029	CcSEcCtD
Methotrexate—Dysgeusia—Triamcinolone—atopic dermatitis	4.76e-05	0.000289	CcSEcCtD
Methotrexate—Vertigo—Prednisolone—atopic dermatitis	4.74e-05	0.000289	CcSEcCtD
Methotrexate—Eye disorder—Dexamethasone—atopic dermatitis	4.73e-05	0.000288	CcSEcCtD
Methotrexate—Eye disorder—Betamethasone—atopic dermatitis	4.73e-05	0.000288	CcSEcCtD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.71e-05	0.00168	CbGpPWpGaD
Methotrexate—Back pain—Triamcinolone—atopic dermatitis	4.7e-05	0.000286	CcSEcCtD
Methotrexate—ALB—Folate Metabolism—IL4—atopic dermatitis	4.7e-05	0.00167	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KIF3A—atopic dermatitis	4.68e-05	0.00167	CbGpPWpGaD
Methotrexate—TYMS—Clobetasol propionate—Desonide—atopic dermatitis	4.68e-05	0.0129	CbGdCrCtD
Methotrexate—Malaise—Hydrocortisone—atopic dermatitis	4.65e-05	0.000283	CcSEcCtD
Methotrexate—Vertigo—Hydrocortisone—atopic dermatitis	4.63e-05	0.000282	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Desonide—atopic dermatitis	4.62e-05	0.0127	CbGdCrCtD
Methotrexate—Diarrhoea—Tacrolimus—atopic dermatitis	4.62e-05	0.000281	CcSEcCtD
Methotrexate—Angiopathy—Dexamethasone—atopic dermatitis	4.59e-05	0.000279	CcSEcCtD
Methotrexate—Angiopathy—Betamethasone—atopic dermatitis	4.59e-05	0.000279	CcSEcCtD
Methotrexate—Convulsion—Prednisolone—atopic dermatitis	4.57e-05	0.000278	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Desonide—atopic dermatitis	4.57e-05	0.0126	CbGdCrCtD
Methotrexate—PGD—Disease—SLC11A1—atopic dermatitis	4.55e-05	0.00162	CbGpPWpGaD
Methotrexate—Ill-defined disorder—Triamcinolone—atopic dermatitis	4.51e-05	0.000274	CcSEcCtD
Methotrexate—Ill-defined disorder—Methylprednisolone—atopic dermatitis	4.5e-05	0.000274	CcSEcCtD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.49e-05	0.0016	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GLB1—atopic dermatitis	4.48e-05	0.0016	CbGpPWpGaD
Methotrexate—Alopecia—Dexamethasone—atopic dermatitis	4.47e-05	0.000272	CcSEcCtD
Methotrexate—Alopecia—Betamethasone—atopic dermatitis	4.47e-05	0.000272	CcSEcCtD
Methotrexate—Convulsion—Hydrocortisone—atopic dermatitis	4.47e-05	0.000272	CcSEcCtD
Methotrexate—Dizziness—Tacrolimus—atopic dermatitis	4.46e-05	0.000272	CcSEcCtD
Methotrexate—Discomfort—Prednisolone—atopic dermatitis	4.44e-05	0.00027	CcSEcCtD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.43e-05	0.00158	CbGpPWpGaD
Methotrexate—Haemoglobin—Prednisone—atopic dermatitis	4.43e-05	0.00027	CcSEcCtD
Methotrexate—Haemorrhage—Prednisone—atopic dermatitis	4.41e-05	0.000268	CcSEcCtD
Methotrexate—Erythema—Betamethasone—atopic dermatitis	4.41e-05	0.000268	CcSEcCtD
Methotrexate—Erythema—Dexamethasone—atopic dermatitis	4.41e-05	0.000268	CcSEcCtD
Methotrexate—Myalgia—Hydrocortisone—atopic dermatitis	4.39e-05	0.000267	CcSEcCtD
Methotrexate—Malaise—Triamcinolone—atopic dermatitis	4.38e-05	0.000267	CcSEcCtD
Methotrexate—AOX1—Disease—GLB1—atopic dermatitis	4.38e-05	0.00156	CbGpPWpGaD
Methotrexate—Malaise—Methylprednisolone—atopic dermatitis	4.37e-05	0.000266	CcSEcCtD
Methotrexate—Vertigo—Triamcinolone—atopic dermatitis	4.36e-05	0.000266	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.36e-05	0.000265	CcSEcCtD
Methotrexate—Vertigo—Methylprednisolone—atopic dermatitis	4.35e-05	0.000265	CcSEcCtD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.35e-05	0.00155	CbGpPWpGaD
Methotrexate—Discomfort—Hydrocortisone—atopic dermatitis	4.34e-05	0.000264	CcSEcCtD
Methotrexate—MTHFR—Selenium Micronutrient Network—IL6—atopic dermatitis	4.31e-05	0.00154	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.31e-05	0.00154	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.31e-05	0.00154	CbGpPWpGaD
Methotrexate—Anaphylactic shock—Prednisolone—atopic dermatitis	4.31e-05	0.000262	CcSEcCtD
Methotrexate—Vomiting—Tacrolimus—atopic dermatitis	4.29e-05	0.000261	CcSEcCtD
Methotrexate—Rash—Tacrolimus—atopic dermatitis	4.25e-05	0.000259	CcSEcCtD
Methotrexate—Dermatitis—Tacrolimus—atopic dermatitis	4.25e-05	0.000259	CcSEcCtD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.24e-05	0.00151	CbGpPWpGaD
Methotrexate—Cough—Triamcinolone—atopic dermatitis	4.24e-05	0.000258	CcSEcCtD
Methotrexate—Headache—Tacrolimus—atopic dermatitis	4.23e-05	0.000257	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Desonide—atopic dermatitis	4.21e-05	0.0116	CbGdCrCtD
Methotrexate—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.21e-05	0.000256	CcSEcCtD
Methotrexate—Convulsion—Triamcinolone—atopic dermatitis	4.21e-05	0.000256	CcSEcCtD
Methotrexate—Convulsion—Methylprednisolone—atopic dermatitis	4.2e-05	0.000255	CcSEcCtD
Methotrexate—Infection—Hydrocortisone—atopic dermatitis	4.18e-05	0.000254	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisolone—atopic dermatitis	4.17e-05	0.000254	CcSEcCtD
Methotrexate—Myalgia—Triamcinolone—atopic dermatitis	4.13e-05	0.000252	CcSEcCtD
Methotrexate—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.13e-05	0.000251	CcSEcCtD
Methotrexate—Myalgia—Methylprednisolone—atopic dermatitis	4.12e-05	0.000251	CcSEcCtD
Methotrexate—Arthralgia—Methylprednisolone—atopic dermatitis	4.12e-05	0.000251	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—atopic dermatitis	4.12e-05	0.000251	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.1e-05	0.000249	CcSEcCtD
Methotrexate—Skin disorder—Hydrocortisone—atopic dermatitis	4.09e-05	0.000249	CcSEcCtD
Methotrexate—Ill-defined disorder—Betamethasone—atopic dermatitis	4.09e-05	0.000249	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.09e-05	0.000249	CcSEcCtD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.09e-05	0.00146	CbGpPWpGaD
Methotrexate—Discomfort—Triamcinolone—atopic dermatitis	4.08e-05	0.000249	CcSEcCtD
Methotrexate—Discomfort—Methylprednisolone—atopic dermatitis	4.08e-05	0.000248	CcSEcCtD
Methotrexate—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.07e-05	0.000248	CcSEcCtD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.05e-05	0.00144	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.03e-05	0.00144	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.02e-05	0.00143	CbGpPWpGaD
Methotrexate—Anorexia—Hydrocortisone—atopic dermatitis	4.01e-05	0.000244	CcSEcCtD
Methotrexate—Nausea—Tacrolimus—atopic dermatitis	4.01e-05	0.000244	CcSEcCtD
Methotrexate—Angiopathy—Prednisone—atopic dermatitis	4e-05	0.000243	CcSEcCtD
Methotrexate—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.99e-05	0.00142	CbGpPWpGaD
Methotrexate—Confusional state—Methylprednisolone—atopic dermatitis	3.99e-05	0.000243	CcSEcCtD
Methotrexate—DHFR—Disease—GLB1—atopic dermatitis	3.98e-05	0.00142	CbGpPWpGaD
Methotrexate—Immune system disorder—Prednisone—atopic dermatitis	3.98e-05	0.000242	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—atopic dermatitis	3.97e-05	0.000242	CcSEcCtD
Methotrexate—Malaise—Betamethasone—atopic dermatitis	3.97e-05	0.000242	CcSEcCtD
Methotrexate—Anaphylactic shock—Triamcinolone—atopic dermatitis	3.96e-05	0.000241	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—atopic dermatitis	3.96e-05	0.000241	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—atopic dermatitis	3.96e-05	0.000241	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—atopic dermatitis	3.95e-05	0.000241	CcSEcCtD
Methotrexate—Infection—Triamcinolone—atopic dermatitis	3.94e-05	0.00024	CcSEcCtD
Methotrexate—Hypotension—Hydrocortisone—atopic dermatitis	3.93e-05	0.000239	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—atopic dermatitis	3.93e-05	0.000239	CcSEcCtD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.9e-05	0.00139	CbGpPWpGaD
Methotrexate—Insomnia—Prednisolone—atopic dermatitis	3.9e-05	0.000237	CcSEcCtD
Methotrexate—Alopecia—Prednisone—atopic dermatitis	3.89e-05	0.000237	CcSEcCtD
Methotrexate—Nervous system disorder—Methylprednisolone—atopic dermatitis	3.88e-05	0.000236	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—atopic dermatitis	3.87e-05	0.000236	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—atopic dermatitis	3.86e-05	0.000235	CcSEcCtD
Methotrexate—Skin disorder—Methylprednisolone—atopic dermatitis	3.84e-05	0.000234	CcSEcCtD
Methotrexate—Erythema—Prednisone—atopic dermatitis	3.84e-05	0.000234	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—atopic dermatitis	3.84e-05	0.000234	CcSEcCtD
Methotrexate—SLC16A1—Hemostasis—IL5—atopic dermatitis	3.84e-05	0.00137	CbGpPWpGaD
Methotrexate—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.83e-05	0.000233	CcSEcCtD
Methotrexate—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.83e-05	0.000233	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.82e-05	0.000233	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.82e-05	0.00136	CbGpPWpGaD
Methotrexate—Convulsion—Betamethasone—atopic dermatitis	3.82e-05	0.000232	CcSEcCtD
Methotrexate—Convulsion—Dexamethasone—atopic dermatitis	3.82e-05	0.000232	CcSEcCtD
Methotrexate—Insomnia—Hydrocortisone—atopic dermatitis	3.81e-05	0.000232	CcSEcCtD
Methotrexate—SLC19A1—Disease—CCR5—atopic dermatitis	3.8e-05	0.00135	CbGpPWpGaD
Methotrexate—Paraesthesia—Hydrocortisone—atopic dermatitis	3.78e-05	0.00023	CcSEcCtD
Methotrexate—ABCC4—Hemostasis—SELE—atopic dermatitis	3.77e-05	0.00135	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GLB1—atopic dermatitis	3.75e-05	0.00134	CbGpPWpGaD
Methotrexate—Myalgia—Betamethasone—atopic dermatitis	3.75e-05	0.000228	CcSEcCtD
Methotrexate—Myalgia—Dexamethasone—atopic dermatitis	3.75e-05	0.000228	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Fluocinonide—atopic dermatitis	3.75e-05	0.0103	CbGdCrCtD
Methotrexate—Discomfort—Dexamethasone—atopic dermatitis	3.71e-05	0.000226	CcSEcCtD
Methotrexate—Discomfort—Betamethasone—atopic dermatitis	3.71e-05	0.000226	CcSEcCtD
Methotrexate—Dyspepsia—Hydrocortisone—atopic dermatitis	3.7e-05	0.000225	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Fluocinonide—atopic dermatitis	3.7e-05	0.0102	CbGdCrCtD
Methotrexate—Hypotension—Methylprednisolone—atopic dermatitis	3.69e-05	0.000225	CcSEcCtD
Methotrexate—TYMS—Budesonide—Desonide—atopic dermatitis	3.69e-05	0.0101	CbGdCrCtD
Methotrexate—Pain—Prednisolone—atopic dermatitis	3.69e-05	0.000224	CcSEcCtD
Methotrexate—AOX1—Metabolism—GLB1—atopic dermatitis	3.67e-05	0.00131	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL10—atopic dermatitis	3.66e-05	0.00131	CbGpPWpGaD
Methotrexate—TYMS—Triamcinolone—Fluocinonide—atopic dermatitis	3.66e-05	0.0101	CbGdCrCtD
Methotrexate—Decreased appetite—Hydrocortisone—atopic dermatitis	3.66e-05	0.000223	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Fluocinolone Acetonide—atopic dermatitis	3.64e-05	0.01	CbGdCrCtD
Methotrexate—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.63e-05	0.000221	CcSEcCtD
Methotrexate—Fatigue—Hydrocortisone—atopic dermatitis	3.63e-05	0.000221	CcSEcCtD
Methotrexate—Vision blurred—Prednisone—atopic dermatitis	3.62e-05	0.00022	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.61e-05	0.00022	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.6e-05	0.000219	CcSEcCtD
Methotrexate—Pain—Hydrocortisone—atopic dermatitis	3.6e-05	0.000219	CcSEcCtD
Methotrexate—MTHFR—Metabolism—ADSL—atopic dermatitis	3.6e-05	0.00128	CbGpPWpGaD
Methotrexate—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.6e-05	0.000219	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—atopic dermatitis	3.6e-05	0.000219	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Fluocinolone Acetonide—atopic dermatitis	3.59e-05	0.00988	CbGdCrCtD
Methotrexate—Insomnia—Triamcinolone—atopic dermatitis	3.58e-05	0.000218	CcSEcCtD
Methotrexate—Insomnia—Methylprednisolone—atopic dermatitis	3.58e-05	0.000218	CcSEcCtD
Methotrexate—Infection—Dexamethasone—atopic dermatitis	3.57e-05	0.000217	CcSEcCtD
Methotrexate—Infection—Betamethasone—atopic dermatitis	3.57e-05	0.000217	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Fluocinonide—atopic dermatitis	3.57e-05	0.00981	CbGdCrCtD
Methotrexate—ABCB1—Allograft Rejection—IL4—atopic dermatitis	3.56e-05	0.00127	CbGpPWpGaD
Methotrexate—Ill-defined disorder—Prednisone—atopic dermatitis	3.56e-05	0.000217	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—atopic dermatitis	3.56e-05	0.000217	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Fluocinolone Acetonide—atopic dermatitis	3.56e-05	0.00978	CbGdCrCtD
Methotrexate—Feeling abnormal—Prednisolone—atopic dermatitis	3.55e-05	0.000216	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—atopic dermatitis	3.55e-05	0.000216	CcSEcCtD
Methotrexate—Anaemia—Prednisone—atopic dermatitis	3.55e-05	0.000216	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—atopic dermatitis	3.53e-05	0.000215	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—atopic dermatitis	3.53e-05	0.000215	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—atopic dermatitis	3.53e-05	0.000215	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.52e-05	0.000214	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—atopic dermatitis	3.52e-05	0.000214	CcSEcCtD
Methotrexate—AOX1—Metabolism—ADSL—atopic dermatitis	3.52e-05	0.00125	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.5e-05	0.00125	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	3.49e-05	0.00124	CbGpPWpGaD
Methotrexate—Dyspepsia—Triamcinolone—atopic dermatitis	3.49e-05	0.000212	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—atopic dermatitis	3.48e-05	0.000212	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—atopic dermatitis	3.48e-05	0.000212	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.48e-05	0.000212	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	3.47e-05	0.00953	CbGdCrCtD
Methotrexate—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.47e-05	0.000211	CcSEcCtD
Methotrexate—Malaise—Prednisone—atopic dermatitis	3.46e-05	0.000211	CcSEcCtD
Methotrexate—Vertigo—Prednisone—atopic dermatitis	3.45e-05	0.00021	CcSEcCtD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.45e-05	0.00123	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.44e-05	0.000209	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—atopic dermatitis	3.43e-05	0.000209	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—atopic dermatitis	3.43e-05	0.000209	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—atopic dermatitis	3.42e-05	0.000208	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—atopic dermatitis	3.42e-05	0.000208	CcSEcCtD
Methotrexate—Fatigue—Methylprednisolone—atopic dermatitis	3.41e-05	0.000207	CcSEcCtD
Methotrexate—Pain—Triamcinolone—atopic dermatitis	3.39e-05	0.000206	CcSEcCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.38e-05	0.0012	CbGpPWpGaD
Methotrexate—TYMS—Diflorasone—Fluocinonide—atopic dermatitis	3.37e-05	0.00927	CbGdCrCtD
Methotrexate—Hypotension—Dexamethasone—atopic dermatitis	3.36e-05	0.000204	CcSEcCtD
Methotrexate—Hypotension—Betamethasone—atopic dermatitis	3.36e-05	0.000204	CcSEcCtD
Methotrexate—Urticaria—Hydrocortisone—atopic dermatitis	3.34e-05	0.000203	CcSEcCtD
Methotrexate—DHFR—Metabolism—GLB1—atopic dermatitis	3.34e-05	0.00119	CbGpPWpGaD
Methotrexate—Abdominal pain—Hydrocortisone—atopic dermatitis	3.33e-05	0.000202	CcSEcCtD
Methotrexate—Body temperature increased—Hydrocortisone—atopic dermatitis	3.33e-05	0.000202	CcSEcCtD
Methotrexate—Convulsion—Prednisone—atopic dermatitis	3.32e-05	0.000202	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Fluocinolone Acetonide—atopic dermatitis	3.28e-05	0.00901	CbGdCrCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.28e-05	0.000199	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.28e-05	0.000199	CcSEcCtD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.27e-05	0.00116	CbGpPWpGaD
Methotrexate—Arthralgia—Prednisone—atopic dermatitis	3.27e-05	0.000199	CcSEcCtD
Methotrexate—Myalgia—Prednisone—atopic dermatitis	3.27e-05	0.000199	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—atopic dermatitis	3.27e-05	0.000199	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.26e-05	0.000198	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—atopic dermatitis	3.25e-05	0.000198	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—atopic dermatitis	3.25e-05	0.000198	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.24e-05	0.000197	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.24e-05	0.00115	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.23e-05	0.000197	CcSEcCtD
Methotrexate—Paraesthesia—Dexamethasone—atopic dermatitis	3.23e-05	0.000197	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—atopic dermatitis	3.23e-05	0.000197	CcSEcCtD
Methotrexate—FPGS—Disease—CCR5—atopic dermatitis	3.23e-05	0.00115	CbGpPWpGaD
Methotrexate—Discomfort—Prednisone—atopic dermatitis	3.23e-05	0.000196	CcSEcCtD
Methotrexate—DHFR—Metabolism—ADSL—atopic dermatitis	3.2e-05	0.00114	CbGpPWpGaD
Methotrexate—Hypersensitivity—Prednisolone—atopic dermatitis	3.17e-05	0.000193	CcSEcCtD
Methotrexate—Dyspepsia—Dexamethasone—atopic dermatitis	3.17e-05	0.000193	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—atopic dermatitis	3.17e-05	0.000193	CcSEcCtD
Methotrexate—Urticaria—Triamcinolone—atopic dermatitis	3.15e-05	0.000192	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—atopic dermatitis	3.14e-05	0.000191	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—atopic dermatitis	3.13e-05	0.000191	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—atopic dermatitis	3.13e-05	0.000191	CcSEcCtD
Methotrexate—Abdominal pain—Methylprednisolone—atopic dermatitis	3.13e-05	0.00019	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—atopic dermatitis	3.13e-05	0.00019	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—atopic dermatitis	3.13e-05	0.00019	CcSEcCtD
Methotrexate—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	3.11e-05	0.00111	CbGpPWpGaD
Methotrexate—Infection—Prednisone—atopic dermatitis	3.11e-05	0.000189	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.1e-05	0.000189	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.1e-05	0.000189	CcSEcCtD
Methotrexate—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.1e-05	0.000189	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—atopic dermatitis	3.1e-05	0.000189	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—atopic dermatitis	3.1e-05	0.000189	CcSEcCtD
Methotrexate—Pain—Betamethasone—atopic dermatitis	3.07e-05	0.000187	CcSEcCtD
Methotrexate—Pain—Dexamethasone—atopic dermatitis	3.07e-05	0.000187	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—atopic dermatitis	3.07e-05	0.000187	CcSEcCtD
Methotrexate—SLC19A1—Metabolism—PPARA—atopic dermatitis	3.05e-05	0.00109	CbGpPWpGaD
Methotrexate—Skin disorder—Prednisone—atopic dermatitis	3.04e-05	0.000185	CcSEcCtD
Methotrexate—SLC16A1—Metabolism—GLB1—atopic dermatitis	3.04e-05	0.00108	CbGpPWpGaD
Methotrexate—Hyperhidrosis—Prednisone—atopic dermatitis	3.03e-05	0.000184	CcSEcCtD
Methotrexate—Asthenia—Hydrocortisone—atopic dermatitis	3.02e-05	0.000184	CcSEcCtD
Methotrexate—MTHFR—Disease—SLC11A1—atopic dermatitis	3e-05	0.00107	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3e-05	0.00107	CbGpPWpGaD
Methotrexate—Anorexia—Prednisone—atopic dermatitis	2.98e-05	0.000182	CcSEcCtD
Methotrexate—Pruritus—Hydrocortisone—atopic dermatitis	2.98e-05	0.000181	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—atopic dermatitis	2.96e-05	0.00018	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—atopic dermatitis	2.96e-05	0.00018	CcSEcCtD
Methotrexate—TYMS—Budesonide—Fluocinonide—atopic dermatitis	2.96e-05	0.00813	CbGdCrCtD
Methotrexate—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.94e-05	0.000179	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.94e-05	0.000179	CcSEcCtD
Methotrexate—AOX1—Disease—SLC11A1—atopic dermatitis	2.93e-05	0.00105	CbGpPWpGaD
Methotrexate—Hypersensitivity—Triamcinolone—atopic dermatitis	2.92e-05	0.000178	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.91e-05	0.000177	CcSEcCtD
Methotrexate—SLC16A1—Metabolism—ADSL—atopic dermatitis	2.91e-05	0.00104	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GLB1—atopic dermatitis	2.91e-05	0.00104	CbGpPWpGaD
Methotrexate—TYMS—Clobetasol propionate—Mometasone—atopic dermatitis	2.91e-05	0.00798	CbGdCrCtD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	2.89e-05	0.00103	CbGpPWpGaD
Methotrexate—Diarrhoea—Hydrocortisone—atopic dermatitis	2.88e-05	0.000175	CcSEcCtD
Methotrexate—TYMS—Budesonide—Fluocinolone Acetonide—atopic dermatitis	2.88e-05	0.0079	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Mometasone—atopic dermatitis	2.87e-05	0.00788	CbGdCrCtD
Methotrexate—ABCC4—Hemostasis—IL5—atopic dermatitis	2.86e-05	0.00102	CbGpPWpGaD
Methotrexate—Urticaria—Betamethasone—atopic dermatitis	2.86e-05	0.000174	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—atopic dermatitis	2.86e-05	0.000174	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.85e-05	0.000174	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—atopic dermatitis	2.85e-05	0.000173	CcSEcCtD
Methotrexate—Asthenia—Triamcinolone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Mometasone—atopic dermatitis	2.84e-05	0.0078	CbGdCrCtD
Methotrexate—ALB—Folate Metabolism—IFNG—atopic dermatitis	2.84e-05	0.00101	CbGpPWpGaD
Methotrexate—Asthenia—Methylprednisolone—atopic dermatitis	2.84e-05	0.000173	CcSEcCtD
Methotrexate—Insomnia—Prednisone—atopic dermatitis	2.83e-05	0.000172	CcSEcCtD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.82e-05	0.00101	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.82e-05	0.001	CbGpPWpGaD
Methotrexate—Paraesthesia—Prednisone—atopic dermatitis	2.81e-05	0.000171	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—atopic dermatitis	2.8e-05	0.000171	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—atopic dermatitis	2.8e-05	0.00017	CcSEcCtD
Methotrexate—TYMS—Metabolism—ADSL—atopic dermatitis	2.79e-05	0.000995	CbGpPWpGaD
Methotrexate—Dizziness—Hydrocortisone—atopic dermatitis	2.78e-05	0.000169	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Mometasone—atopic dermatitis	2.77e-05	0.00761	CbGdCrCtD
Methotrexate—Dyspepsia—Prednisone—atopic dermatitis	2.76e-05	0.000168	CcSEcCtD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.73e-05	0.000974	CbGpPWpGaD
Methotrexate—Decreased appetite—Prednisone—atopic dermatitis	2.72e-05	0.000166	CcSEcCtD
Methotrexate—Rash—Prednisolone—atopic dermatitis	2.72e-05	0.000165	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—atopic dermatitis	2.71e-05	0.000165	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—atopic dermatitis	2.71e-05	0.000165	CcSEcCtD
Methotrexate—TYMS—Circadian rythm related genes—MAPK8—atopic dermatitis	2.7e-05	0.000964	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.7e-05	0.000963	CbGpPWpGaD
Methotrexate—Fatigue—Prednisone—atopic dermatitis	2.7e-05	0.000164	CcSEcCtD
Methotrexate—Headache—Prednisolone—atopic dermatitis	2.7e-05	0.000164	CcSEcCtD
Methotrexate—Vomiting—Hydrocortisone—atopic dermatitis	2.68e-05	0.000163	CcSEcCtD
Methotrexate—SLCO1B3—Metabolism—GLB1—atopic dermatitis	2.67e-05	0.000952	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC11A1—atopic dermatitis	2.67e-05	0.000951	CbGpPWpGaD
Methotrexate—Rash—Hydrocortisone—atopic dermatitis	2.65e-05	0.000162	CcSEcCtD
Methotrexate—Dermatitis—Hydrocortisone—atopic dermatitis	2.65e-05	0.000161	CcSEcCtD
Methotrexate—Headache—Hydrocortisone—atopic dermatitis	2.64e-05	0.00016	CcSEcCtD
Methotrexate—Dizziness—Triamcinolone—atopic dermatitis	2.62e-05	0.000159	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Mometasone—atopic dermatitis	2.62e-05	0.00719	CbGdCrCtD
Methotrexate—Dizziness—Methylprednisolone—atopic dermatitis	2.61e-05	0.000159	CcSEcCtD
Methotrexate—ATIC—Metabolism—PPARA—atopic dermatitis	2.59e-05	0.000924	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PPARA—atopic dermatitis	2.59e-05	0.000924	CbGpPWpGaD
Methotrexate—Feeling abnormal—Prednisone—atopic dermatitis	2.58e-05	0.000157	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—atopic dermatitis	2.58e-05	0.000157	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—atopic dermatitis	2.58e-05	0.000157	CcSEcCtD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.57e-05	0.000915	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Prednisone—atopic dermatitis	2.56e-05	0.000156	CcSEcCtD
Methotrexate—SLCO1B3—Metabolism—ADSL—atopic dermatitis	2.56e-05	0.000913	CbGpPWpGaD
Methotrexate—Nausea—Prednisolone—atopic dermatitis	2.56e-05	0.000156	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—atopic dermatitis	2.54e-05	0.000155	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—atopic dermatitis	2.54e-05	0.000155	CcSEcCtD
Methotrexate—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	2.53e-05	0.000903	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL1B—atopic dermatitis	2.53e-05	0.000903	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL2—atopic dermatitis	2.52e-05	0.000899	CbGpPWpGaD
Methotrexate—Vomiting—Triamcinolone—atopic dermatitis	2.52e-05	0.000153	CcSEcCtD
Methotrexate—SLC46A1—Disease—CCR5—atopic dermatitis	2.51e-05	0.000896	CbGpPWpGaD
Methotrexate—Vomiting—Methylprednisolone—atopic dermatitis	2.51e-05	0.000153	CcSEcCtD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	2.51e-05	0.000895	CbGpPWpGaD
Methotrexate—Nausea—Hydrocortisone—atopic dermatitis	2.5e-05	0.000152	CcSEcCtD
Methotrexate—Rash—Triamcinolone—atopic dermatitis	2.5e-05	0.000152	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—atopic dermatitis	2.5e-05	0.000152	CcSEcCtD
Methotrexate—Rash—Methylprednisolone—atopic dermatitis	2.49e-05	0.000152	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—atopic dermatitis	2.49e-05	0.000152	CcSEcCtD
Methotrexate—Urticaria—Prednisone—atopic dermatitis	2.49e-05	0.000151	CcSEcCtD
Methotrexate—Headache—Triamcinolone—atopic dermatitis	2.48e-05	0.000151	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—atopic dermatitis	2.48e-05	0.000151	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—atopic dermatitis	2.48e-05	0.000151	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—atopic dermatitis	2.48e-05	0.000151	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—atopic dermatitis	2.46e-05	0.00015	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—atopic dermatitis	2.46e-05	0.00015	CcSEcCtD
Methotrexate—ABCC3—Metabolism—GLB1—atopic dermatitis	2.41e-05	0.000859	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CD4—atopic dermatitis	2.38e-05	0.00085	CbGpPWpGaD
Methotrexate—Dizziness—Dexamethasone—atopic dermatitis	2.38e-05	0.000145	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—atopic dermatitis	2.38e-05	0.000145	CcSEcCtD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.38e-05	0.000847	CbGpPWpGaD
Methotrexate—Nausea—Triamcinolone—atopic dermatitis	2.35e-05	0.000143	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—atopic dermatitis	2.35e-05	0.000143	CcSEcCtD
Methotrexate—ABCC3—Metabolism—ADSL—atopic dermatitis	2.31e-05	0.000823	CbGpPWpGaD
Methotrexate—Hypersensitivity—Prednisone—atopic dermatitis	2.31e-05	0.00014	CcSEcCtD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.3e-05	0.00082	CbGpPWpGaD
Methotrexate—PGD—Disease—CCR5—atopic dermatitis	2.3e-05	0.00082	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Mometasone—atopic dermatitis	2.29e-05	0.0063	CbGdCrCtD
Methotrexate—Vomiting—Dexamethasone—atopic dermatitis	2.29e-05	0.000139	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—atopic dermatitis	2.29e-05	0.000139	CcSEcCtD
Methotrexate—Rash—Dexamethasone—atopic dermatitis	2.27e-05	0.000138	CcSEcCtD
Methotrexate—Rash—Betamethasone—atopic dermatitis	2.27e-05	0.000138	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—atopic dermatitis	2.27e-05	0.000138	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—atopic dermatitis	2.27e-05	0.000138	CcSEcCtD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	2.26e-05	0.000805	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	2.25e-05	0.000804	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GLB1—atopic dermatitis	2.25e-05	0.000804	CbGpPWpGaD
Methotrexate—Headache—Betamethasone—atopic dermatitis	2.25e-05	0.000137	CcSEcCtD
Methotrexate—Headache—Dexamethasone—atopic dermatitis	2.25e-05	0.000137	CcSEcCtD
Methotrexate—Asthenia—Prednisone—atopic dermatitis	2.25e-05	0.000137	CcSEcCtD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.23e-05	0.000795	CbGpPWpGaD
Methotrexate—Pruritus—Prednisone—atopic dermatitis	2.22e-05	0.000135	CcSEcCtD
Methotrexate—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	2.15e-05	0.000768	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.15e-05	0.000765	CbGpPWpGaD
Methotrexate—Diarrhoea—Prednisone—atopic dermatitis	2.14e-05	0.00013	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—atopic dermatitis	2.14e-05	0.00013	CcSEcCtD
Methotrexate—Nausea—Betamethasone—atopic dermatitis	2.14e-05	0.00013	CcSEcCtD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	2.12e-05	0.000756	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KIF3A—atopic dermatitis	2.12e-05	0.000755	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.11e-05	0.00075	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GLB1—atopic dermatitis	2.1e-05	0.000748	CbGpPWpGaD
Methotrexate—Dizziness—Prednisone—atopic dermatitis	2.07e-05	0.000126	CcSEcCtD
Methotrexate—FPGS—Disease—CD4—atopic dermatitis	2.03e-05	0.000723	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PPARA—atopic dermatitis	2.02e-05	0.00072	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	2.01e-05	0.000717	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ADSL—atopic dermatitis	2.01e-05	0.000717	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	2e-05	0.000714	CbGpPWpGaD
Methotrexate—Vomiting—Prednisone—atopic dermatitis	1.99e-05	0.000121	CcSEcCtD
Methotrexate—Rash—Prednisone—atopic dermatitis	1.97e-05	0.00012	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—atopic dermatitis	1.97e-05	0.00012	CcSEcCtD
Methotrexate—Headache—Prednisone—atopic dermatitis	1.96e-05	0.000119	CcSEcCtD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.95e-05	0.000694	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.95e-05	0.000694	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.92e-05	0.000685	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.91e-05	0.000682	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.89e-05	0.000675	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GLB1—atopic dermatitis	1.89e-05	0.000673	CbGpPWpGaD
Methotrexate—Nausea—Prednisone—atopic dermatitis	1.86e-05	0.000113	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.85e-05	0.00066	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARA—atopic dermatitis	1.85e-05	0.000658	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—atopic dermatitis	1.84e-05	0.000655	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	1.82e-05	0.00065	CbGpPWpGaD
Methotrexate—TYMS—Flunisolide—Hydrocortisone—atopic dermatitis	1.82e-05	0.00499	CbGdCrCtD
Methotrexate—ABCC1—Metabolism—ADSL—atopic dermatitis	1.81e-05	0.000645	CbGpPWpGaD
Methotrexate—TYMS—Triamcinolone—Hydrocortisone—atopic dermatitis	1.8e-05	0.00494	CbGdCrCtD
Methotrexate—SLCO1B1—Metabolism—GLB1—atopic dermatitis	1.79e-05	0.00064	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.76e-05	0.000626	CbGpPWpGaD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—atopic dermatitis	1.74e-05	0.00477	CbGdCrCtD
Methotrexate—TYMS—Circadian rythm related genes—IL6—atopic dermatitis	1.73e-05	0.000616	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ADSL—atopic dermatitis	1.72e-05	0.000613	CbGpPWpGaD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—atopic dermatitis	1.71e-05	0.00471	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—atopic dermatitis	1.71e-05	0.00469	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—atopic dermatitis	1.71e-05	0.00469	CbGdCrCtD
Methotrexate—ALB—Hemostasis—SELE—atopic dermatitis	1.71e-05	0.000609	CbGpPWpGaD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—atopic dermatitis	1.7e-05	0.00466	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—atopic dermatitis	1.69e-05	0.00463	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—atopic dermatitis	1.69e-05	0.00463	CbGdCrCtD
Methotrexate—ABCC3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.67e-05	0.000595	CbGpPWpGaD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—atopic dermatitis	1.67e-05	0.00459	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—atopic dermatitis	1.67e-05	0.00458	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—atopic dermatitis	1.67e-05	0.00458	CbGdCrCtD
Methotrexate—ABCG2—Metabolism—GLB1—atopic dermatitis	1.66e-05	0.000592	CbGpPWpGaD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	1.65e-05	0.00454	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—atopic dermatitis	1.65e-05	0.00453	CbGdCrCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.64e-05	0.000584	CbGpPWpGaD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—atopic dermatitis	1.63e-05	0.00447	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—atopic dermatitis	1.63e-05	0.00447	CbGdCrCtD
Methotrexate—ABCG2—Metabolism—ADSL—atopic dermatitis	1.59e-05	0.000568	CbGpPWpGaD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—atopic dermatitis	1.59e-05	0.00437	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—atopic dermatitis	1.58e-05	0.00435	CbGdCrCtD
Methotrexate—SLC46A1—Disease—CD4—atopic dermatitis	1.58e-05	0.000563	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.57e-05	0.000559	CbGpPWpGaD
Methotrexate—TYMS—Flunisolide—Prednisone—atopic dermatitis	1.56e-05	0.0043	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—atopic dermatitis	1.56e-05	0.00429	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—atopic dermatitis	1.55e-05	0.00425	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—atopic dermatitis	1.55e-05	0.00425	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—atopic dermatitis	1.54e-05	0.00423	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—atopic dermatitis	1.54e-05	0.00423	CbGdCrCtD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.53e-05	0.000545	CbGpPWpGaD
Methotrexate—TYMS—Flunisolide—Prednisolone—atopic dermatitis	1.53e-05	0.00419	CbGdCrCtD
Methotrexate—MTHFR—Disease—CCR5—atopic dermatitis	1.52e-05	0.000541	CbGpPWpGaD
Methotrexate—TYMS—Triamcinolone—Prednisolone—atopic dermatitis	1.51e-05	0.00415	CbGdCrCtD
Methotrexate—ABCC1—Disease—SLC11A1—atopic dermatitis	1.51e-05	0.000538	CbGpPWpGaD
Methotrexate—TYMS—Diflorasone—Triamcinolone—atopic dermatitis	1.5e-05	0.00413	CbGdCrCtD
Methotrexate—ALB—Folate Metabolism—IL6—atopic dermatitis	1.48e-05	0.000529	CbGpPWpGaD
Methotrexate—AOX1—Disease—CCR5—atopic dermatitis	1.48e-05	0.000528	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.47e-05	0.000523	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—atopic dermatitis	1.47e-05	0.000522	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	1.46e-05	0.00052	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.45e-05	0.000518	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Hydrocortisone—atopic dermatitis	1.45e-05	0.00399	CbGdCrCtD
Methotrexate—PGD—Disease—CD4—atopic dermatitis	1.44e-05	0.000515	CbGpPWpGaD
Methotrexate—TYMS—Diflorasone—Prednisone—atopic dermatitis	1.43e-05	0.00392	CbGdCrCtD
Methotrexate—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.39e-05	0.000497	CbGpPWpGaD
Methotrexate—TYMS—Diflorasone—Prednisolone—atopic dermatitis	1.39e-05	0.00382	CbGdCrCtD
Methotrexate—TYMS—Danazol—Hydrocortisone—atopic dermatitis	1.39e-05	0.00382	CbGdCrCtD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.39e-05	0.000494	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.38e-05	0.00049	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Methylprednisolone—atopic dermatitis	1.37e-05	0.00376	CbGdCrCtD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.37e-05	0.000487	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Betamethasone—atopic dermatitis	1.35e-05	0.0037	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—atopic dermatitis	1.35e-05	0.0037	CbGdCrCtD
Methotrexate—DHFR—Disease—CCR5—atopic dermatitis	1.35e-05	0.000481	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.32e-05	0.000472	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Triamcinolone—atopic dermatitis	1.32e-05	0.00362	CbGdCrCtD
Methotrexate—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.31e-05	0.000466	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.31e-05	0.000466	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL5—atopic dermatitis	1.29e-05	0.000461	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—atopic dermatitis	1.29e-05	0.00046	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.28e-05	0.000458	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Prednisone—atopic dermatitis	1.25e-05	0.00344	CbGdCrCtD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.25e-05	0.000446	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.24e-05	0.000443	CbGpPWpGaD
Methotrexate—TYMS—Budesonide—Prednisolone—atopic dermatitis	1.22e-05	0.00335	CbGdCrCtD
Methotrexate—MTHFR—Metabolism—PPARA—atopic dermatitis	1.22e-05	0.000434	CbGpPWpGaD
Methotrexate—TYMS—Danazol—Prednisone—atopic dermatitis	1.2e-05	0.00329	CbGdCrCtD
Methotrexate—AOX1—Metabolism—PPARA—atopic dermatitis	1.19e-05	0.000424	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	1.18e-05	0.00042	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.15e-05	0.00041	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—atopic dermatitis	1.1e-05	0.000391	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—atopic dermatitis	1.09e-05	0.00039	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARA—atopic dermatitis	1.08e-05	0.000386	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GLB1—atopic dermatitis	1.02e-05	0.000365	CbGpPWpGaD
Methotrexate—TYMS—Levonorgestrel—Hydrocortisone—atopic dermatitis	9.98e-06	0.00274	CbGdCrCtD
Methotrexate—SLC16A1—Metabolism—PPARA—atopic dermatitis	9.86e-06	0.000351	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADSL—atopic dermatitis	9.83e-06	0.00035	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	9.59e-06	0.000342	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—atopic dermatitis	9.53e-06	0.00034	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARA—atopic dermatitis	9.45e-06	0.000337	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—atopic dermatitis	9.31e-06	0.000332	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GLB1—atopic dermatitis	8.98e-06	0.00032	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	8.69e-06	0.00031	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARA—atopic dermatitis	8.67e-06	0.000309	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADSL—atopic dermatitis	8.61e-06	0.000307	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—atopic dermatitis	8.54e-06	0.000304	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—atopic dermatitis	8.47e-06	0.000302	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARA—atopic dermatitis	7.82e-06	0.000279	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—atopic dermatitis	7.81e-06	0.000278	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—atopic dermatitis	7.63e-06	0.000272	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.47e-06	0.000266	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.1e-06	0.000253	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	6.88e-06	0.000245	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARA—atopic dermatitis	6.81e-06	0.000243	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.22e-06	0.000222	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARA—atopic dermatitis	6.13e-06	0.000218	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARA—atopic dermatitis	5.82e-06	0.000208	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARA—atopic dermatitis	5.39e-06	0.000192	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—atopic dermatitis	5.15e-06	0.000184	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—atopic dermatitis	5.03e-06	0.000179	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—atopic dermatitis	4.94e-06	0.000176	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—atopic dermatitis	4.79e-06	0.000171	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—atopic dermatitis	4.58e-06	0.000163	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARA—atopic dermatitis	3.33e-06	0.000119	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARA—atopic dermatitis	2.91e-06	0.000104	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—atopic dermatitis	2.59e-06	9.24e-05	CbGpPWpGaD
